Coassembly of hypoxia-sensitive macrocyclic amphiphiles and extracellular vesicles for targeted kidney injury imaging and therapy

Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be establishe...

Full description

Saved in:
Bibliographic Details
Published inJournal of nanobiotechnology Vol. 19; no. 1; pp. 451 - 21
Main Authors Cheng, Yuan-Qiu, Yue, Yu-Xin, Cao, Hong-Mei, Geng, Wen-Chao, Wang, Lan-Xing, Hu, Xin-Yue, Li, Hua-Bin, Bian, Qiang, Kong, Xiang-Lei, Liu, Jian-Feng, Kong, De-Ling, Guo, Dong-Sheng, Wang, Yue-Bing
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 27.12.2021
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α β and α β , where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects. This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs.
AbstractList Background Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). Results In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α4β1 and αLβ2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects. Conclusion This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs.
Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor [alpha].sub.4[beta].sub.1 and [alpha].sub.L[beta].sub.2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1[alpha] expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-?B signaling pathway to exert their regenerative effects. This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs.
Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α β and α β , where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects. This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs.
Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs).BACKGROUNDHypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs).In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α4β1 and αLβ2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects.RESULTSIn murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α4β1 and αLβ2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects.This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs.CONCLUSIONThis synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs.
Background Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). Results In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor [alpha].sub.4[beta].sub.1 and [alpha].sub.L[beta].sub.2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1[alpha] expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-?B signaling pathway to exert their regenerative effects. Conclusion This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs. Graphical Keywords: Supramolecular chemistry, Extracellular vesicles, Macrocyclic amphiphile, Kidney hypoxia, Coassembly
Abstract Background Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). Results In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α4β1 and αLβ2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects. Conclusion This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs. Graphical Abstract
ArticleNumber 451
Audience Academic
Author Bian, Qiang
Cao, Hong-Mei
Cheng, Yuan-Qiu
Wang, Lan-Xing
Geng, Wen-Chao
Guo, Dong-Sheng
Kong, Xiang-Lei
Kong, De-Ling
Hu, Xin-Yue
Yue, Yu-Xin
Wang, Yue-Bing
Li, Hua-Bin
Liu, Jian-Feng
Author_xml – sequence: 1
  givenname: Yuan-Qiu
  surname: Cheng
  fullname: Cheng, Yuan-Qiu
– sequence: 2
  givenname: Yu-Xin
  surname: Yue
  fullname: Yue, Yu-Xin
– sequence: 3
  givenname: Hong-Mei
  surname: Cao
  fullname: Cao, Hong-Mei
– sequence: 4
  givenname: Wen-Chao
  surname: Geng
  fullname: Geng, Wen-Chao
– sequence: 5
  givenname: Lan-Xing
  surname: Wang
  fullname: Wang, Lan-Xing
– sequence: 6
  givenname: Xin-Yue
  surname: Hu
  fullname: Hu, Xin-Yue
– sequence: 7
  givenname: Hua-Bin
  surname: Li
  fullname: Li, Hua-Bin
– sequence: 8
  givenname: Qiang
  surname: Bian
  fullname: Bian, Qiang
– sequence: 9
  givenname: Xiang-Lei
  surname: Kong
  fullname: Kong, Xiang-Lei
– sequence: 10
  givenname: Jian-Feng
  surname: Liu
  fullname: Liu, Jian-Feng
– sequence: 11
  givenname: De-Ling
  surname: Kong
  fullname: Kong, De-Ling
– sequence: 12
  givenname: Dong-Sheng
  surname: Guo
  fullname: Guo, Dong-Sheng
– sequence: 13
  givenname: Yue-Bing
  orcidid: 0000-0001-6988-0788
  surname: Wang
  fullname: Wang, Yue-Bing
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34961540$$D View this record in MEDLINE/PubMed
BookMark eNp9kktr3DAUhU1JaR7tH-iiGLppF04ljeTHphCGPgYChT7WQpavPZra0lSSJ_Gy_7zXM0nJhFJsIyN956B77zlPTqyzkCQvKbmktMzfBcoqQTPC8KO0YtnNk-SM8qLIFlSIkwf_p8l5CBtCGOOMP0tOF7zKqeDkLPm9dCoEGOp-Sl2brqetuzUqC2CDiWYH6aC0d3rSvdGpGrZrg28PIVW2SeE2eqWh78de-XQHwej5qHU-jcp3EKFJf5rGwpQauxk9LoPqjO326rgGr7bT8-Rpq_oAL-7Wi-THxw_fl5-z6y-fVsur60yLqohZSVvIBWdlVdO2XigAJoDpJietEG2DOwXUTPGGEs0LlmuhW17VRSmwVMQWF8nq4Ns4tZFbj1fxk3TKyP2G851UPs4VSMpAVIrmtKoEp5qqnPJGlDUXNdGaN-j1_uC1HesBGg0WG9EfmR6fWLOWndvJsqCcswoN3twZePdrhBDlYMLcSWXBjUEyHA8lZZXP6OtH6MaN3mKrkGKULArBHlCdwgKMbd08mtlUXqFJLgpScqQu_0Hh08BgNKarxdkeC94eCZCJOPVOjSHI1bevx-yrh0352437sCFQHgBMVAgeWqlNVNG4uUeml5TIOdfykGuJuZb7XMsblLJH0nv3_4j-AFgy--I
CitedBy_id crossref_primary_10_1016_j_cej_2023_148138
crossref_primary_10_1021_accountsmr_3c00130
crossref_primary_10_1002_ps_7492
crossref_primary_10_1002_cjoc_202200714
crossref_primary_10_1021_acs_molpharmaceut_2c01079
crossref_primary_10_1021_acs_accounts_3c00585
crossref_primary_10_1002_asia_202200106
crossref_primary_10_1002_anie_202213578
crossref_primary_10_1038_s41467_023_41388_2
crossref_primary_10_1002_adhm_202300263
crossref_primary_10_1002_adhm_202402480
crossref_primary_10_1002_smll_202301019
crossref_primary_10_1016_j_ijpharm_2024_124786
crossref_primary_10_1016_j_supmat_2024_100063
crossref_primary_10_1016_j_bioactmat_2025_02_018
crossref_primary_10_1016_j_supmat_2025_100101
crossref_primary_10_2217_nnm_2023_0200
crossref_primary_10_1007_s11426_023_1857_2
crossref_primary_10_1186_s12951_025_03181_9
crossref_primary_10_1002_adma_202306583
crossref_primary_10_1186_s12951_024_02906_6
crossref_primary_10_1155_sci_1075016
crossref_primary_10_3390_pharmaceutics14081733
crossref_primary_10_1016_j_jconrel_2024_03_017
crossref_primary_10_1021_acsami_3c08756
crossref_primary_10_1016_j_bioactmat_2022_08_002
crossref_primary_10_3390_molecules28165934
crossref_primary_10_1002_adfm_202314607
crossref_primary_10_1016_j_colsurfb_2023_113598
crossref_primary_10_1016_j_cytogfr_2023_12_006
crossref_primary_10_2147_IJN_S456533
crossref_primary_10_1016_j_jconrel_2022_03_041
crossref_primary_10_1021_acsnano_2c03597
crossref_primary_10_1016_j_mtbio_2025_101646
crossref_primary_10_1039_D2CC06286K
crossref_primary_10_1002_ange_202213578
crossref_primary_10_2147_IJN_S452393
crossref_primary_10_3390_molecules27113457
Cites_doi 10.1016/S0009-8981(01)00596-4
10.1093/jn/137.9.2013
10.1038/nrneph.2015.214
10.1038/nrneph.2017.98
10.1002/anie.201813397
10.2174/156720510790274392
10.1016/j.chembiol.2010.09.012
10.1021/acsnano.8b09776
10.1016/j.freeradbiomed.2018.08.019
10.1016/j.coi.2012.01.010
10.1161/HYPERTENSIONAHA.115.05578
10.1002/anie.201705578
10.1681/ASN.2017050523
10.1016/j.tibtech.2018.11.012
10.1002/anie.201709457
10.1016/j.kint.2018.09.013
10.1080/20013078.2020.1806444
10.1038/nature22341
10.1021/jacs.8b02331
10.1021/ja105937q
10.1039/D0SC03922E
10.1038/nrneph.2014.180
10.1002/anie.202001355
10.1016/j.addr.2020.04.004
10.1111/j.1523-1755.2005.09909.x
10.1111/febs.13578
10.3389/fphys.2017.00099
10.1016/j.addr.2016.02.006
10.1021/jacs.8b03584
10.1038/ki.2015.21
10.1002/adfm.201905671
10.1016/j.mam.2015.12.004
10.1039/C5CC05518K
10.1016/j.kint.2017.09.033
10.1038/s41467-020-16439-7
10.1002/anie.201308368
10.1038/s41467-020-18626-y
10.1016/j.biomaterials.2016.11.023
10.3121/cmr.2015.1282
10.1166/jbn.2018.2598
10.1039/C8CS00304A
10.1016/j.kint.2019.04.034
10.1016/j.kint.2016.10.020
10.1038/s41581-019-0182-z
10.1172/JCI69073
10.1681/ASN.2009060615
10.1038/nrneph.2010.124
10.1021/acsnano.9b08207
10.1073/pnas.2014352117
10.1002/(SICI)1521-3773(19980202)37:1/2<112::AID-ANIE112>3.0.CO;2-O
10.1002/smll.201903135
10.1016/j.biomaterials.2020.120467
10.1186/s40824-016-0068-0
10.1021/acs.chemrev.6b00525
10.1038/nrneph.2015.215
10.1088/2050-6120/3/4/044004
10.2215/CJN.13201019
10.1021/acs.nanolett.1c00488
10.1002/anie.202011185
ContentType Journal Article
Copyright 2021. The Author(s).
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. The Author(s).
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID AAYXX
CITATION
NPM
ISR
3V.
7QO
7TB
7X7
7XB
88E
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
CCPQU
COVID
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB.
LK8
M0S
M1P
M7P
P64
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12951-021-01192-w
DatabaseName CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Mechanical & Transportation Engineering Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
Biotechnology and BioEngineering Abstracts
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Mechanical & Transportation Engineering Abstracts
ProQuest Central Essentials
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
Materials Science Database
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Materials Science Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

PubMed
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 1477-3155
EndPage 21
ExternalDocumentID oai_doaj_org_article_12e59a16199541c1a614d58b45b0cc4d
PMC8714429
A693657084
34961540
10_1186_s12951_021_01192_w
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 51873090
– fundername: National Natural Science Foundation of China
  grantid: 81830060
– fundername: National Basic Research Program of China (973 Program)
  grantid: 2020YFA0803700
– fundername: National Natural Science Foundation of China
  grantid: U20A20259
– fundername: National Natural Science Foundation of China
  grantid: 81971670
– fundername: ;
  grantid: 81971670; U20A20259; 81830060; 51873090
– fundername: ;
  grantid: 2020YFA0803700; 2020YFA0803700
GroupedDBID ---
0R~
29L
2WC
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADDVE
ADMLS
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
D1I
DIK
DU5
E3Z
EBD
EBLON
EBS
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
I-F
IAO
IHR
INH
INR
ISR
ITC
ITG
ITH
KB.
KQ8
LK8
M1P
M48
M7P
MM.
M~E
O5R
O5S
OK1
OVT
P2P
PDBOC
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
RVI
SCM
SOJ
SV3
TR2
TUS
UKHRP
WOQ
WOW
XSB
~8M
-A0
3V.
ACRMQ
ADINQ
C24
FRP
NPM
PMFND
7QO
7TB
7XB
8FD
8FK
AZQEC
COVID
DWQXO
FR3
GNUQQ
K9.
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c597t-81fe654289b1fb3aee25e2cd60f55fdb3a7eb2a4d10c4726c5cf49b785961cd63
IEDL.DBID M48
ISSN 1477-3155
IngestDate Wed Aug 27 01:28:35 EDT 2025
Thu Aug 21 13:40:53 EDT 2025
Fri Jul 11 06:51:15 EDT 2025
Fri Jul 25 19:31:21 EDT 2025
Tue Jun 17 21:05:40 EDT 2025
Tue Jun 10 20:36:30 EDT 2025
Fri Jun 27 04:19:54 EDT 2025
Wed Feb 19 02:27:24 EST 2025
Tue Jul 01 01:26:48 EDT 2025
Thu Apr 24 23:00:12 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Coassembly
Extracellular vesicles
Macrocyclic amphiphile
Kidney hypoxia
Supramolecular chemistry
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c597t-81fe654289b1fb3aee25e2cd60f55fdb3a7eb2a4d10c4726c5cf49b785961cd63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6988-0788
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12951-021-01192-w
PMID 34961540
PQID 2621037529
PQPubID 44676
PageCount 21
ParticipantIDs doaj_primary_oai_doaj_org_article_12e59a16199541c1a614d58b45b0cc4d
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8714429
proquest_miscellaneous_2615108969
proquest_journals_2621037529
gale_infotracmisc_A693657084
gale_infotracacademiconefile_A693657084
gale_incontextgauss_ISR_A693657084
pubmed_primary_34961540
crossref_citationtrail_10_1186_s12951_021_01192_w
crossref_primary_10_1186_s12951_021_01192_w
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-12-27
PublicationDateYYYYMMDD 2021-12-27
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-27
  day: 27
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of nanobiotechnology
PublicationTitleAlternate J Nanobiotechnology
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References F Emma (1192_CR3) 2016; 12
Z-L Li (1192_CR5) 2019; 95
I Mimura (1192_CR11) 2010; 6
D Karpman (1192_CR34) 2017; 13
Y-C Pan (1192_CR44) 2020; 60
KU Eckardt (1192_CR2) 2005; 68
G Cheng (1192_CR53) 2018; 140
PP Kapitsinou (1192_CR58) 2014; 124
H Cao (1192_CR33) 2020; 14
H Ono (1192_CR38) 2001; 312
Q Huang (1192_CR50) 2020; 11
RH Fang (1192_CR66) 2018; 30
L D'Ignazio (1192_CR62) 2016; 283
K Kiyose (1192_CR15) 2010; 132
T-X Zhang (1192_CR23) 2020; 32
ZZ Zhang (1192_CR24) 2021; 33
P Bonnitcha (1192_CR12) 2018; 126
T-T Tang (1192_CR35) 2020; 6
S Kamerkar (1192_CR30) 2017; 546
Q Fu (1192_CR61) 2016; 14
MP Chao (1192_CR54) 2012; 24
W-C Geng (1192_CR51) 2020; 59
Y-C Pan (1192_CR46) 2020; 2
L-L Lv (1192_CR7) 2018; 29
1192_CR55
J Gao (1192_CR45) 2018; 140
LL Lv (1192_CR64) 2017; 91
F Perche (1192_CR16) 2014; 53
A Chevalier (1192_CR18) 2015; 3
OM Elsharkasy (1192_CR28) 2020; 159
L Liu (1192_CR31) 2020; 6
Y Kodama (1192_CR13) 2019; 96
R Luo (1192_CR63) 2015; 66
L Rao (1192_CR25) 2019
F Arnaud-Neu (1192_CR43) 1998; 37
Y-Y Yang (1192_CR47) 2010; 17
P Vader (1192_CR32) 2016; 106
L Rao (1192_CR68) 2020; 117
P Yuan (1192_CR19) 2017; 56
CPC Ow (1192_CR1) 2018; 222
V Agrahari (1192_CR36) 2019; 37
W Nassar (1192_CR37) 2016; 20
HR Jang (1192_CR65) 2015; 11
D Zhou (1192_CR9) 2016; 12
L Rao (1192_CR26) 2018; 57
PI Creeke (1192_CR39) 2007; 137
J Yamaguchi (1192_CR60) 2015; 88
J Schodel (1192_CR59) 2019; 15
B-C Liu (1192_CR6) 2018; 93
A Sharma (1192_CR21) 2019; 48
Q Cai (1192_CR17) 2015; 51
H Choi (1192_CR52) 2020; 6
P Verwilst (1192_CR48) 2017; 115
DF Higgins (1192_CR10) 2007; 117
L Rao (1192_CR27) 2020; 11
W-C Geng (1192_CR22) 2019; 58
A Srivastava (1192_CR14) 2020; 15
DJ Llewellyn (1192_CR40) 2010; 7
L Ge (1192_CR42) 2021; 21
J Xin (1192_CR49) 2018; 14
EP Cummins (1192_CR57) 2016; 47–48
H Cao (1192_CR41) 2019; 13
M Zhuang (1192_CR56) 2019; 15
Y Hirakawa (1192_CR4) 2017; 8
S Lee (1192_CR8) 2011; 22
J-N Liu (1192_CR20) 2017; 117
C Gao (1192_CR67) 2020; 11
Z Belhadj (1192_CR29) 2020; 9
References_xml – volume: 312
  start-page: 227
  year: 2001
  ident: 1192_CR38
  publication-title: Clin Chim Acta
  doi: 10.1016/S0009-8981(01)00596-4
– volume: 137
  start-page: 2013
  year: 2007
  ident: 1192_CR39
  publication-title: J Nutr
  doi: 10.1093/jn/137.9.2013
– volume: 12
  start-page: 267
  year: 2016
  ident: 1192_CR3
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2015.214
– volume: 13
  start-page: 545
  year: 2017
  ident: 1192_CR34
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2017.98
– volume: 30
  year: 2018
  ident: 1192_CR66
  publication-title: Adv Mater
– volume: 58
  start-page: 2377
  year: 2019
  ident: 1192_CR22
  publication-title: Angew Chem Int Edit
  doi: 10.1002/anie.201813397
– volume: 7
  start-page: 91
  year: 2010
  ident: 1192_CR40
  publication-title: Curr Alzheimer Res
  doi: 10.2174/156720510790274392
– volume: 17
  start-page: 1212
  year: 2010
  ident: 1192_CR47
  publication-title: Chem Biol
  doi: 10.1016/j.chembiol.2010.09.012
– volume: 13
  start-page: 3522
  year: 2019
  ident: 1192_CR41
  publication-title: ACS Nano
  doi: 10.1021/acsnano.8b09776
– volume: 126
  start-page: 296
  year: 2018
  ident: 1192_CR12
  publication-title: Free Radic Biol Med
  doi: 10.1016/j.freeradbiomed.2018.08.019
– volume: 24
  start-page: 225
  year: 2012
  ident: 1192_CR54
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2012.01.010
– volume: 32
  year: 2020
  ident: 1192_CR23
  publication-title: Adv Mater
– volume: 66
  start-page: 75
  year: 2015
  ident: 1192_CR63
  publication-title: Hypertension
  doi: 10.1161/HYPERTENSIONAHA.115.05578
– volume: 56
  start-page: 12481
  year: 2017
  ident: 1192_CR19
  publication-title: Angew Chem Int Edit
  doi: 10.1002/anie.201705578
– volume: 29
  start-page: 919
  year: 2018
  ident: 1192_CR7
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2017050523
– volume: 37
  start-page: 707
  year: 2019
  ident: 1192_CR36
  publication-title: Trends Biotechnol
  doi: 10.1016/j.tibtech.2018.11.012
– volume: 57
  start-page: 986
  year: 2018
  ident: 1192_CR26
  publication-title: Angew Chem Int Edit
  doi: 10.1002/anie.201709457
– volume: 95
  start-page: 388
  year: 2019
  ident: 1192_CR5
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2018.09.013
– volume: 9
  start-page: 1806444
  year: 2020
  ident: 1192_CR29
  publication-title: J Extracell Vesicles
  doi: 10.1080/20013078.2020.1806444
– volume: 546
  start-page: 498
  year: 2017
  ident: 1192_CR30
  publication-title: Nature
  doi: 10.1038/nature22341
– volume: 6
  year: 2020
  ident: 1192_CR31
  publication-title: Sci Adv
– volume: 140
  start-page: 4945
  year: 2018
  ident: 1192_CR45
  publication-title: J Am Chem Soc
  doi: 10.1021/jacs.8b02331
– volume: 132
  start-page: 15846
  year: 2010
  ident: 1192_CR15
  publication-title: J Am Chem Soc
  doi: 10.1021/ja105937q
– volume: 11
  start-page: 9623
  year: 2020
  ident: 1192_CR50
  publication-title: Chem Sci
  doi: 10.1039/D0SC03922E
– volume: 6
  year: 2020
  ident: 1192_CR52
  publication-title: Sci Adv
– volume: 11
  start-page: 88
  year: 2015
  ident: 1192_CR65
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2014.180
– volume: 59
  start-page: 12684
  year: 2020
  ident: 1192_CR51
  publication-title: Angew Chem Int Edit
  doi: 10.1002/anie.202001355
– volume: 159
  start-page: 332
  year: 2020
  ident: 1192_CR28
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2020.04.004
– volume: 2
  start-page: 2485
  year: 2020
  ident: 1192_CR46
  publication-title: CCS Chem
– volume: 68
  start-page: S46
  year: 2005
  ident: 1192_CR2
  publication-title: Kidney Int Suppl
  doi: 10.1111/j.1523-1755.2005.09909.x
– volume: 222
  year: 2018
  ident: 1192_CR1
  publication-title: Acta Physiol
– volume: 283
  start-page: 413
  year: 2016
  ident: 1192_CR62
  publication-title: FEBS J
  doi: 10.1111/febs.13578
– volume: 117
  start-page: 3810
  year: 2007
  ident: 1192_CR10
  publication-title: J Clin Invest
– volume: 8
  start-page: 99
  year: 2017
  ident: 1192_CR4
  publication-title: Front Physiol
  doi: 10.3389/fphys.2017.00099
– volume: 106
  start-page: 148
  year: 2016
  ident: 1192_CR32
  publication-title: Adv Drug Deliv Rev
  doi: 10.1016/j.addr.2016.02.006
– volume: 140
  start-page: 7282
  year: 2018
  ident: 1192_CR53
  publication-title: J Am Chem Soc
  doi: 10.1021/jacs.8b03584
– volume: 88
  start-page: 262
  year: 2015
  ident: 1192_CR60
  publication-title: Kidney Int
  doi: 10.1038/ki.2015.21
– year: 2019
  ident: 1192_CR25
  publication-title: Adv Funct Mater
  doi: 10.1002/adfm.201905671
– volume: 47–48
  start-page: 24
  year: 2016
  ident: 1192_CR57
  publication-title: Mol Asp Med
  doi: 10.1016/j.mam.2015.12.004
– volume: 51
  start-page: 14739
  year: 2015
  ident: 1192_CR17
  publication-title: Chem Commun
  doi: 10.1039/C5CC05518K
– volume: 93
  start-page: 568
  year: 2018
  ident: 1192_CR6
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2017.09.033
– volume: 33
  year: 2021
  ident: 1192_CR24
  publication-title: Adv Mater
– volume: 11
  start-page: 2622
  year: 2020
  ident: 1192_CR67
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-16439-7
– volume: 53
  start-page: 3362
  year: 2014
  ident: 1192_CR16
  publication-title: Angew Chem Int Edit
  doi: 10.1002/anie.201308368
– volume: 11
  start-page: 4909
  year: 2020
  ident: 1192_CR27
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-18626-y
– volume: 115
  start-page: 104
  year: 2017
  ident: 1192_CR48
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2016.11.023
– volume: 14
  start-page: 15
  year: 2016
  ident: 1192_CR61
  publication-title: Clin Med Res
  doi: 10.3121/cmr.2015.1282
– volume: 14
  start-page: 1430
  year: 2018
  ident: 1192_CR49
  publication-title: J Biomed Nanotechnol
  doi: 10.1166/jbn.2018.2598
– volume: 48
  start-page: 771
  year: 2019
  ident: 1192_CR21
  publication-title: Chem Soc Rev
  doi: 10.1039/C8CS00304A
– volume: 96
  start-page: 787
  year: 2019
  ident: 1192_CR13
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2019.04.034
– volume: 91
  start-page: 587
  year: 2017
  ident: 1192_CR64
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2016.10.020
– volume: 15
  start-page: 641
  year: 2019
  ident: 1192_CR59
  publication-title: Nat Rev Nephrol
  doi: 10.1038/s41581-019-0182-z
– volume: 124
  start-page: 2396
  year: 2014
  ident: 1192_CR58
  publication-title: J Clin Invest
  doi: 10.1172/JCI69073
– volume: 22
  start-page: 317
  year: 2011
  ident: 1192_CR8
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2009060615
– volume: 6
  start-page: 667
  year: 2010
  ident: 1192_CR11
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2010.124
– volume: 14
  start-page: 4014
  year: 2020
  ident: 1192_CR33
  publication-title: ACS Nano
  doi: 10.1021/acsnano.9b08207
– volume: 117
  start-page: 27141
  year: 2020
  ident: 1192_CR68
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.2014352117
– volume: 37
  start-page: 112
  year: 1998
  ident: 1192_CR43
  publication-title: Angew Chem Int Edit
  doi: 10.1002/(SICI)1521-3773(19980202)37:1/2<112::AID-ANIE112>3.0.CO;2-O
– volume: 15
  year: 2019
  ident: 1192_CR56
  publication-title: Small
  doi: 10.1002/smll.201903135
– ident: 1192_CR55
  doi: 10.1016/j.biomaterials.2020.120467
– volume: 20
  start-page: 21
  year: 2016
  ident: 1192_CR37
  publication-title: Biomater Res
  doi: 10.1186/s40824-016-0068-0
– volume: 117
  start-page: 6160
  year: 2017
  ident: 1192_CR20
  publication-title: Chem Soc Rev
  doi: 10.1021/acs.chemrev.6b00525
– volume: 12
  start-page: 68
  year: 2016
  ident: 1192_CR9
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2015.215
– volume: 3
  year: 2015
  ident: 1192_CR18
  publication-title: Methods Appl. Fluoresc.
  doi: 10.1088/2050-6120/3/4/044004
– volume: 15
  start-page: 776
  year: 2020
  ident: 1192_CR14
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.13201019
– volume: 6
  year: 2020
  ident: 1192_CR35
  publication-title: Sci Adv
– volume: 21
  start-page: 3218
  year: 2021
  ident: 1192_CR42
  publication-title: Nano Lett
  doi: 10.1021/acs.nanolett.1c00488
– volume: 60
  start-page: 1875
  year: 2020
  ident: 1192_CR44
  publication-title: Angew Chem Int Edit
  doi: 10.1002/anie.202011185
SSID ssj0022424
Score 2.4529924
Snippet Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic...
Background Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and...
Abstract Background Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 451
SubjectTerms Adenosine
Aluminum
Analysis
Animal models
Apoptosis
Care and treatment
Chronic kidney failure
Coassembly
Diagnosis
Epithelial cells
Epithelium
Extracellular vesicles
Fibrosis
Fluorescence
Hypoxia
Hypoxia-inducible factor 1a
Injuries
Ischemia
Kidney diseases
Kidney hypoxia
Kidneys
Macrocycles
Macrocyclic amphiphile
Macrophages
Medical imaging
Mesenchyme
Metabolism
NF-κB protein
Receptors
Reperfusion
Risk factors
Scientific imaging
Self-assembly
Signal transduction
Sodium
Stem cells
Supramolecular chemistry
Vesicles
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT3BAvFkoyCAkDihq7LWd5FgqqsKBA1CpN8tPGthNqma3bY78c2ac7GojJLgg7SkeS8nM2PPN6psZQt5ErooqlD4Db5GZiNJl1iuWQWzwhfC8KExiW3xWJ6fi05k82xn1hZywoT3woLgDxoOsDOASbFzGHDMQT7wsrZA2d054vH0h5m2SqTHVwqKHTYlMqQ46iGoS0maOqTNgmux6EoZSt_4_7-SdoDQlTO5EoON75O4IHenh8Mr3ya3QPCB3dhoKPiS_jloAw2FpFz1tIz3vL9qb2mQdstTxXqNLA-_jereoHTVgyBp-i9BR03gK1_SlwT_ykZlKr0KXGHMUUC0d-OLB05-1b0JP6-YH2ILWyzTjKO0eCrn6R-T0-MO3o5NsHLKQOcglVmCUGHBoVVlZFu3chMBl4M6rPEoZPTwpIPk2wrPciYIrJ10UlS1KWSkGYvPHZK9pm_CU0Ijo08Yq8NyCqDW5UcYZxiD-iTAXM8I2Otdu7ECOgzAWOmUipdKDnTTYSSc76esZebfdczH03_ir9Hs05VYSe2enB-BRevQo_S-PmpHX6Agau2M0SL_5btZdpz9-_aIPVTVHrlAJ3_J2FIotGseM1QygCWyoNZHcn0jC8XXT5Y2_6fH66DRXHOs3Ja9m5NV2GXciJa4J7RplAKzlZaVA5sngntvvxikAgI3zGSkmjjtRzHSlqc9Tc3FIoAVglGf_Q5PPyW2OZ45hBdg-2VtdrsMLwHAr-zId19_agUS6
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgvMAD4puOgQxC4gFFi93YSZ7QmJgGDzwAk_pm-XMLtEnXtIw-8p9z56RdI6RJfYrPUuI7n3_n_u6OkLeBy7z0hUvAWkSSBWET4yRL4GxweeZ4nuvItvgqT8-yLxMx6S_c2p5WufGJ0VG7xuId-SGXHFPaBC8_zC8T7BqF_672LTRukztYugwpXfnkOuDC1IdNokwhD1s42wQEzxwDaEA2ydXgMIo1-__3zDtH05A2uXMOnTwg93sASY86jT8kt3z9iNzbKSv4mPw9bgAS-5mZrmkT6MV63vypdNIiVx29G51peB-7ttPKUg3qrOA39S3VtaPgrBcar_ORn0p_-zby5ihgW9qxxr2jvypX-zWt6p-gEVrNYqejOLtL51o_IWcnn34cnyZ9q4XEQkSxBNUEj62ritKwYMbaey48t06mQYjg4EkOIbjOHEttlnNphQ1ZafJClJKB2Pgp2aub2j8nNCAGNaH0PDUganSqpbaaMTgFMz_ORoRt1lzZvg45tsOYqhiPFFJ1elKgJxX1pK5G5P12zryrwnGj9EdU5VYSK2jHB83iXPUbUjHuRakB72JBPGaZBpziRGEyYVJrMzcib9AQFNbIqJGEc65Xbas-f_-mjmQ5RsZQAd_yrhcKDSpH9zkNsBJYVmsgeTCQhE1sh8Mbe1O9E2nVtcmPyOvtMM5EYlztmxXKAGRLi1KCzLPOPLffjb0AACGnI5IPDHewMMORurqIJcYhjM4Aqezf_FovyF2Ou4lhhtcB2VsuVv4lYLSleRU34j9mXTzx
  priority: 102
  providerName: ProQuest
Title Coassembly of hypoxia-sensitive macrocyclic amphiphiles and extracellular vesicles for targeted kidney injury imaging and therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/34961540
https://www.proquest.com/docview/2621037529
https://www.proquest.com/docview/2615108969
https://pubmed.ncbi.nlm.nih.gov/PMC8714429
https://doaj.org/article/12e59a16199541c1a614d58b45b0cc4d
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELf28QIPiO8VRmUQEg8okLi2kzwgtE0rA4kJDSr1zXJsZwu0yWhatj7yn3PnpFUjJiSkqA_xOUp8d77fufdByMucyTh1iQ1AWkTAc2GCzMooANtgY25ZHGsfbXEqT0b801iMt8iq3VG7gPWNrh32kxrNJm-ufy7fg8K_8wqfyLc12CwBTjFDxxgQS3C1TXbBMsWoqJ_5-l8FhqkQPtsoxrM5IVZJNDc-o2OofD3_v3ftDbPVDancsFHDu-ROCy7pQSMN98iWK--T2xslBx-Q30cVwGU3zSZLWuX0YnlZXRc6qDGOHXc-OtXwPmZpJoWhGlhdwDVxNdWlpbCRzzQe9WPsKv3lah9TRwH30iai3Fn6o7ClW9Ki_A7cosXUd0Hys5tUr-VDMhoefzs6Cdo2DIEBb2MObMsdtrVK0izKs4F2jgnHjJVhLkRu4U4M7rnmNgoNj5k0wuQ8zeJEpDICssEjslNWpdsjNEd8muWpY2EGpJkOtdRGR8CqhLsB75FotebKtDXKsVXGRHlfJZGq4ZMCPinPJ3XVI6_Xcy6bCh3_pD5EVq4psbq2v1HNzlWrrCpiTqQasDAWy4tMpAHDWJFkXGShMdz2yAsUBIX1M0oM0DnXi7pWH7-eqQOZDjCaKIFvedUS5RUyR7f5DrASWHKrQ7nfoQQFN93hlbyplX4oJhlmeAqW9sjz9TDOxKC50lULpAE4FyapBJrHjXiuvxv7BAB6Dnsk7ghuZ2G6I2Vx4cuPg4vNAcU8-a91f0puMVSuCJPB9snOfLZwzwDOzbM-2Y7HMfwmww99snt4fPrlrO-PRvpee_8AUIVKng
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOQAHxJuFAgaBOKCoiTd2kgNCpVDt0tIDtNLejGM7bdrdZNnssuTIH-I3MpPHdiOk3irlFI8jxzOe-SaZByGvEyaCyIbGAWnhjp9w7cRGeA7YBhP4hgWBqqItDsXg2P8y4qMN8rfNhcGwylYnVora5Bq_kW8zwTCljbPow_Sng12j8O9q20KjFot9Wy7BZSveDz8Bf98wtvf5aHfgNF0FHA3geQ6rSCx2aQqj2EvivrKWccu0EW7CeWLgTgDepvKN52o_YEJznfhRHIQ8Eh6Q9eG518h1MLwunqhgdOHgYapFm5gTiu0CbCkHZ52hww5Iyll2jF_VI-B_S7BmCrthmmt2b-8Oud0AVrpTS9hdsmGze-TWWhnD--TPbg4Q3E7icUnzhJ6W0_x3qpwCY-NRm9KJgvXoUo9TTRWITwrX2BZUZYaCcZgp_H2A8bD0ly2qOD0KWJrWUerW0PPUZLakaXYGEkDTSdVZqZpdp4-VD8jxlTDhIdnM8sw-JjRBzBsnkWVuDKSxcpVQWnkeWF3f9v0e8do9l7qpe47tN8ay8n9CIWs-SeCTrPgklz3ybjVnWlf9uJT6I7JyRYkVu6sb-exENgpAeszySAG-xgJ8nvYU4CLDw9jnsau1b3rkFQqCxJocGQb9nKhFUcjh929yR0R9jFAK4V3eNkRJjsxRTQ4F7ASW8epQbnUoQWno7nArb7JRWoW8OGI98nI1jDMxEC-z-QJpACK6YSSA5lEtnqv3xt4DgMjdHgk6gtvZmO5Ilp5WJc3BbfcBGT25fFkvyI3B0dcDeTA83H9KbjI8WR5ml22RzflsYZ8BPpzHz6tDScmPq9YC_wDgAnrO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Coassembly+of+hypoxia-sensitive+macrocyclic+amphiphiles+and+extracellular+vesicles+for+targeted+kidney+injury+imaging+and+therapy&rft.jtitle=Journal+of+nanobiotechnology&rft.au=Cheng%2C+Yuan-Qiu&rft.au=Yue%2C+Yu-Xin&rft.au=Cao%2C+Hong-Mei&rft.au=Geng%2C+Wen-Chao&rft.date=2021-12-27&rft.issn=1477-3155&rft.eissn=1477-3155&rft.volume=19&rft.issue=1&rft_id=info:doi/10.1186%2Fs12951-021-01192-w&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12951_021_01192_w
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-3155&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-3155&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-3155&client=summon